1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9 Ack1
Results for "

1380424-42-9

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-18977
    KML29

    MAGL Metabolic Disease Inflammation/Immunology
    KML29 is an extremely selective, orally active and irreversible MAGL inhibitor, with IC50 values of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively. KML29 exhibits minimal cross-reactivity toward other central and peripheral serine hydrolases, including no detectable activity against FAAH.